Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
30 Octobre 2023 - 2:00PM
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial
results for the quarter ended September 30, 2023 before the market
opens on November 7, 2023, and will hold a conference call to
discuss the results at 8:00 a.m. Eastern Time.
Participants who would like to join the call and ask a question
must register here. Once registered, you will receive the
dial-in numbers and a unique PIN number.
Participants who would like to join the audio-only webcast
should go to our events and presentations on the investor
website here.
Financial information presented on the call, including the
earnings release and a related slide presentation, will be
available on the Investor Relations section of Harvard Bioscience’s
website.
About Harvard Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer
and seller of technologies, products and services that enable
fundamental advances in life science applications, including
research, pharmaceutical and therapy discovery, bio-production and
preclinical testing for pharmaceutical and therapy development. Our
customers range from renowned academic institutions and government
laboratories to the world’s leading pharmaceutical, biotechnology
and contract research organizations. With operations in North
America, Europe, and China, we sell through a combination of direct
and distribution channels to customers around the world. For more
information, please visit our website
at www.harvardbioscience.com.
Investor Inquiries:Harvard Bioscience,
Inc.Investor Relationsinvestors@harvardbioscience.com (508)
893-3120
Harvard Bioscience (NASDAQ:HBIO)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Harvard Bioscience (NASDAQ:HBIO)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024